(Reuters Health) – Male physicians in the U.S., across almost every specialty, took in more money from the biomedical industry in 2015 than their female peers, a new study suggests.
Source: Reuters Medical News
Leaving the house linked to longevity in older adults
(Reuters Health) – For older people, getting out of the house regularly may contribute to a longer life – and the effect is independent of medical problems or mobility issues, according to new research from Israel.
Source: Reuters Medical News
Kmart to pay $32 million to settle drug overbilling allegations
WASHINGTON (Reuters) – Kmart Corp, a unit of Sears Holdings Corp, has agreed to pay $32.3 million to settle allegations that its pharmacies failed to report discounted prescription drug prices to federal health programs, the U.S. Justice Department said on Friday.
Source: Reuters Medical News
Students may be getting more concussions in PE classes than in sports
(Reuters Health) – Education and research about concussions in youth have focused on team sports, but a study from New Mexico suggests that adolescents may suffer more knock-out head blows in PE classes than in organized athletics.
Source: Reuters Medical News
U.S. FDA plans to let device makers report malfunctions less frequently
(Reuters) – The U.S. Food and Drug Administration on Friday said it plans to let medical device makers report less serious malfunctions of some devices on a quarterly basis to cut down on repeated reviews of common problems.
Source: Reuters Medical News
Novelion unit asks U.S. judge to approve plea deal, cites money woes
BOSTON (Reuters) – Aegerion Pharmaceuticals Inc has asked a U.S. judge to quickly approve a new plea agreement aimed at resolving probes into its promotion of a cholesterol drug, saying its parent company has been blocked from capital markets due to the case’s uncertainty.
Source: Reuters Medical News
FDA rejects Agile's contraceptive patch, shares plunge
(Reuters) – Agile Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its contraceptive patch for the second time, sending the drug developer’s shares down about 50 percent.
Source: Reuters Medical News
Exclusive: U.S. cancer drugmaker Ignyta in advanced sale talks – sources
(Reuters) – Ignyta Inc is in advanced talks to sell itself, people familiar with the matter said on Thursday, just three years after the U.S. cancer drugmaker became a public company focused on precision drugs and diagnostics.
Source: Reuters Medical News
Obamacare enrollment down only slightly after late surge in demand
NEW YORK (Reuters) – Slightly fewer Americans have enrolled for insurance through the federal Obamacare marketplace compared to a year ago, the government said on Thursday, but the number was higher than expected in light of steps taken by President Donald Trump and Congress to undermine the 2010 law.
Source: Reuters Medical News
Opioid crisis trims U.S. life expectancy, boosts hepatitis C: CDC
CHICAGO (Reuters) – The opioid crisis is rippling through the U.S. healthcare system, causing a spike in rates of hepatitis C related to increased opioid injections and reducing overall life expectancy among Americans, which has fallen for the second year in a row, U.S. health officials said on Thursday.
Source: Reuters Medical News